Evolent Health
EVH
70 hedge funds and large institutions have $174M invested in Evolent Health in 2016 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 31 increasing their positions, 12 reducing their positions, and 12 closing their positions.
158% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 12
11% more capital inflows, than outflows
Capital inflows: $27.9M | Capital outflows: $25M
1% more funds holding
Funds holding: 69 → 70 (+1)
8% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 12
0.1% less ownership
Funds ownership: 38.79% → 38.69% (-0.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Pennant Capital Management
Summit,
New Jersey
|
+$4.94M |
| 2 |
Perceptive Advisors
New York
|
+$4.87M |
| 3 |
JP Morgan Chase
New York
|
+$3.74M |
| 4 |
ECP
Elk Creek Partners
Denver,
Colorado
|
+$2.18M |
| 5 |
TimesSquare Capital Management
New York
|
+$2.15M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$13M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
-$4.31M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$1.37M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.21M |
| 5 |
Granahan Investment Management
Waltham,
Massachusetts
|
-$1.16M |
EVH Hedge Fund Activity: Q1 2016 in Review
70 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q1 2016, worth a combined $174M — down 11% from $195M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new EVH positions and 12 closed out — a net gain of 1 holder — while 31 added to existing stakes and 12 trimmed.
The largest buyer was Pennant Capital Management, adding an estimated $4.94M. The largest seller was Lord, Abbett & Co, cutting an estimated $13M.
- 70 institutional investors held Evolent Health (EVH) as of Q1 2016, up from 69 in Q4 2015.
- Funds reported $174M of Evolent Health stock for Q1 2016, down 11% quarter-over-quarter.
- 13 funds opened new Evolent Health positions in Q1 2016 and 12 closed out, a net change of +1 holder.
- The largest Evolent Health buyer in Q1 2016 was Pennant Capital Management, an estimated $4.94M added.
- The largest Evolent Health seller in Q1 2016 was Lord, Abbett & Co, an estimated $13M sold.
Based on aggregated 13F filings for Q1 2016.